These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16231045)

  • 21. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
    Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
    BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand.
    Bowsher RR; Sailstad JM
    J Pharm Biomed Anal; 2008 Dec; 48(5):1282-9. PubMed ID: 18977625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical aspects regarding the application of GPL principles to new compounds such as biotechnology products.
    Brunetti MM
    Ann Ist Super Sanita; 2008; 44(4):385-9. PubMed ID: 19352001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. Examples of application.
    Hubert P; Nguyen-Huu JJ; Boulanger B; Chapuzet E; Cohen N; Compagnon PA; Dewé W; Feinberg M; Laurentie M; Mercier N; Muzard G; Valat L; Rozet E
    J Pharm Biomed Anal; 2008 Nov; 48(3):760-71. PubMed ID: 18768284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
    Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A risk-based analysis of the AAPS conference report on quantitative bioanalytical methods validation and implementation.
    Boulanger B; Rozet E; Moonen F; Rudaz S; Hubert P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2235-43. PubMed ID: 19577965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET
    Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of various international guidelines for analytical method validation.
    Chandran S; Singh RS
    Pharmazie; 2007 Jan; 62(1):4-14. PubMed ID: 17294806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of high-performance liquid chromatography-tandem mass spectrometry assay for 6-(3-benzoyl-ureido)-hexanoic acid hydroxyamide, a novel HDAC inhibitor, in mouse plasma for pharmacokinetic studies.
    Yeo P; Xin L; Goh E; New LS; Zeng P; Wu X; Venkatesh P; Kantharaj E
    Biomed Chromatogr; 2007 Feb; 21(2):184-9. PubMed ID: 17221921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of new methods.
    Peters FT; Drummer OH; Musshoff F
    Forensic Sci Int; 2007 Jan; 165(2-3):216-24. PubMed ID: 16781833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of detecting methods of digoxin blood drug level].
    Li YX; Mao JY; Li HF
    Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(4):285-8, 326. PubMed ID: 17455457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept.
    Rozet E; Hubert C; Ceccato A; Dewé W; Ziemons E; Moonen F; Michail K; Wintersteiger R; Streel B; Boulanger B; Hubert P
    J Chromatogr A; 2007 Jul; 1158(1-2):126-37. PubMed ID: 17420025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assay validation and biological variation of serum receptor for advanced glycation end-products.
    Brown LF; Fraser CG
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):518-9. PubMed ID: 18753428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of recent pharmaceutical regulatory documents on analytical method validation.
    Rozet E; Ceccato A; Hubert C; Ziemons E; Oprean R; Rudaz S; Boulanger B; Hubert P
    J Chromatogr A; 2007 Jul; 1158(1-2):111-25. PubMed ID: 17420026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of biological assays.
    Schofield T
    Dev Biol (Basel); 2002; 107():25-32. PubMed ID: 12079188
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
    Simek SL
    Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When gene medication is also genetic modification--regulating DNA treatment.
    Foss GS; Rogne S
    Vaccine; 2007 Jul; 25(30):5613-8. PubMed ID: 17544178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of analytical quality specifications for biomarker assays currently used in acute cardiac care.
    Panteghini M
    Acute Card Care; 2006; 8(3):133-8. PubMed ID: 17012126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome amplification methods in gene expression profiling.
    Peano C; Severgnini M; Cifola I; De Bellis G; Battaglia C
    Expert Rev Mol Diagn; 2006 May; 6(3):465-80. PubMed ID: 16706747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.